» Articles » PMID: 32130894

Mitochondrial Pyruvate Carrier 1 Promotes Peripheral T Cell Homeostasis Through Metabolic Regulation of Thymic Development

Overview
Journal Cell Rep
Publisher Cell Press
Date 2020 Mar 5
PMID 32130894
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic pathways regulate T cell development and function, but many remain understudied. Recently, the mitochondrial pyruvate carrier (MPC) was identified as the transporter that mediates pyruvate entry into mitochondria, promoting pyruvate oxidation. Here we find that deleting Mpc1, an obligate MPC subunit, in the hematopoietic system results in a specific reduction in peripheral αβ T cell numbers. MPC1-deficient T cells have defective thymic development at the β-selection, intermediate single positive (ISP)-to-double-positive (DP), and positive selection steps. We find that early thymocytes deficient in MPC1 display alterations to multiple pathways involved in T cell development. This results in preferred escape of more activated T cells. Finally, mice with hematopoietic deletion of Mpc1 are more susceptible to experimental autoimmune encephalomyelitis. Altogether, our study demonstrates that pyruvate oxidation by T cell precursors is necessary for optimal αβ T cell development and that its deficiency results in reduced but activated peripheral T cell populations.

Citing Articles

Food for thought: Nutrient metabolism controlling early T cell development.

Werlen G, Hernandez T, Jacinto E Bioessays. 2024; 47(1):e2400179.

PMID: 39504233 PMC: 11662157. DOI: 10.1002/bies.202400179.


Immune aging: biological mechanisms, clinical symptoms, and management in lung transplant recipients.

Kapse B, Budev M, Singer J, Greenland J Front Transplant. 2024; 3:1356948.

PMID: 38993782 PMC: 11235310. DOI: 10.3389/frtra.2024.1356948.


Lkb1 orchestrates γδ T-cell metabolic and functional fitness to control IL-17-mediated autoimmune hepatitis.

Xiao Z, Wang S, Luo L, Lv W, Feng P, Sun Y Cell Mol Immunol. 2024; 21(6):546-560.

PMID: 38641698 PMC: 11143210. DOI: 10.1038/s41423-024-01163-9.


Blocking Mitochondrial Pyruvate Transport Alters Corneal Myofibroblast Phenotype: A New Target for Treating Fibrosis.

Jeon K, Kumar A, Callan C, DeMagistris M, MacRae S, Nehrke K Invest Ophthalmol Vis Sci. 2023; 64(13):36.

PMID: 37870848 PMC: 10599161. DOI: 10.1167/iovs.64.13.36.


Mitochondrial dysfunctions in T cells: focus on inflammatory bowel disease.

Lee H, Jeon J, Kim E Front Immunol. 2023; 14:1219422.

PMID: 37809060 PMC: 10556505. DOI: 10.3389/fimmu.2023.1219422.


References
1.
Rothenberg E, Moore J, Yui M . Launching the T-cell-lineage developmental programme. Nat Rev Immunol. 2007; 8(1):9-21. PMC: 3131407. DOI: 10.1038/nri2232. View

2.
Bantug G, Fischer M, Grahlert J, Balmer M, Unterstab G, Develioglu L . Mitochondria-Endoplasmic Reticulum Contact Sites Function as Immunometabolic Hubs that Orchestrate the Rapid Recall Response of Memory CD8 T Cells. Immunity. 2018; 48(3):542-555.e6. PMC: 6049611. DOI: 10.1016/j.immuni.2018.02.012. View

3.
Biancone L, Bowen M, Lim A, Aruffo A, Andres G, Stamenkovic I . Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes. J Exp Med. 1996; 184(3):811-9. PMC: 2192762. DOI: 10.1084/jem.184.3.811. View

4.
Buck M, OSullivan D, Pearce E . T cell metabolism drives immunity. J Exp Med. 2015; 212(9):1345-60. PMC: 4548052. DOI: 10.1084/jem.20151159. View

5.
Lin Q, Dong C, Cooper M . Impairment of T and B cell development by treatment with a type I interferon. J Exp Med. 1998; 187(1):79-87. PMC: 2199191. DOI: 10.1084/jem.187.1.79. View